Vimarsana
Biggest News Aggregation in the World

David Setboun News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from David Setboun. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In David Setboun Today - Breaking & Trending Today

Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease - Vimarsana News

Alkeus Announces $150 Million Series B Financing, Supporting Rapid Registration Path for gildeuretinol (ALK-001) in the Treatment of Stargardt Disease

Published: June 5, 2023

Forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Source: forextv.com
Related Topics:
New Zealand GeneralNew ZealandUnited KingdomDavid SetbounLeonide SaadJoshua BogerBain Capital Life SciencesAlkeus PharmaceuticalsVertex PharmaceuticalsVertex FounderIndustry Pioneer Joshua BogerExecutive ChairmanWellington ManagementBreakthrough Therapy DesignationOrphan Drug DesignationIlyas WashingtonChief Operating
Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript - Vimarsana News

Brainstorm Cell Therapeutics Inc. (NASDAQ:BCLI) Q4 2022 Earnings Call Transcript

Published: April 6, 2023

Operator: Greetings, and welcome to the Brainstorm Cell Therapeutics Fourth Quarter 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Source: insidermonkey.com
Related Topics:
United StatesMichael WoodChaim LebovitsJason MccarthyStacy LindborgRaymond JamesDavid SetbounHealth PhotoAssociation ClinicalJason Mccarthy At Maxim GroupAccess ProgramBrainstorm Cell Therapeutics IncBrainstorm Cell TherapeuticsCall Transcript MarchBrainstorm Cell Therapeutics Fourth QuarterChaim Lebovits PresidentCo Chief Executive OfficerAlla PatlisInterim Chief FinancialChief Operating OfficerFile Over ProtestAnnual Muscular DystrophyInfo MycellhubExpanded AccessExpanded Access Program
BrainStorm to Announce Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update - Vimarsana News

BrainStorm to Announce Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update

Published: March 21, 2023

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...

Source: prnewswire.com
Related Topics:
United StatesJohn MullalyDavid SetbounChaim LebovitsLisa GuitermanStacy LindborgCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncLifesci AdvisorsDrug AdministrationPrnewswire Brainstorm Cell Therapeutics IncNational Ms SocietyEuropean Medicines AgencyStorm Cell TherapeuticsChief Executive OfficerCo Chief Executive OfficerExecutive Vice PresidentChief Operating OfficerAlla PatlisInterim Chief FinancialReplay NumberReplay ExpirationOrphan DrugCalifornia InstituteRegenerative Medicine
BrainStorm Cell Therapeutics to Announce Third Quarter Results and Provide a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics to Announce Third Quarter Results and Provide a Corporate Update

Published: November 7, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Source: prnewswire.com
Related Topics:
United StatesJohn MullalyDavid SetbounRalph KernChaim LebovitsLisa GuitermanStacy LindborgCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncLifesci AdvisorsDrug AdministrationPrnewswire Brainstorm Cell Therapeutics IncNational Ms SocietyEuropean Medicines AgencyStorm Cell TherapeuticsChief Executive OfficerChief Medical OfficerExecutive Vice PresidentChief Development OfficerChief Operating OfficerAlla PatlisInterim Chief FinancialThursday NovemberOrphan DrugCalifornia Institute
BrainStorm to Announce Second Quarter Results and Provide a Corporate Update - Vimarsana News

BrainStorm to Announce Second Quarter Results and Provide a Corporate Update

Published: August 1, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced today...

Source: prnewswire.com
Related Topics:
United StatesJohn MullalyDavid SetbounRalph KernChaim LebovitsStacy LindborgCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncLifesci AdvisorsDrug AdministrationPrnewswire Brainstorm Cell Therapeutics IncNational Ms SocietyEuropean Medicines AgencyStorm Cell TherapeuticsChief Executive OfficerChief Medical OfficerExecutive Vice PresidentChief Development OfficerChief Operating OfficerAlla PatlisInterim Chief FinancialAccess CodeCell TherapeuticsOrphan DrugCalifornia Institute